Overview
DERM AI platform for assessing and triaging skin lesions on urgent suspected skin cancer pathways, deployed with health-system partners and supported by Class III CE certification for autonomous clinical decisions.
Product and company
Skin Analytics — Digital Health is a verified product offering linked to the Brel Digital company profile for Skin Analytics.
Use cases
DERM AI platform for assessing and triaging skin lesions on urgent suspected skin cancer pathways, deployed with health-system partners and supported by Class III CE certification for autonomous clinical decisions.
Target customer
Dermatology services, NHS and European health systems, insurers, and primary care networks managing high-volume skin lesion referrals.
Technologies
Primary technologies assigned from the linked company profile: Computer Vision, Deep Learning, Healthcare Analytics, Machine Learning, Predictive Analytics, Responsible AI.
Sources and references
- Official product / company source: https://skin-analytics.com/news/regulatory-certification/derm-class-iii-ce-mark/
- Supporting source: https://skin-analytics.com/news/funding/series-b-15million-funding/
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- DERM AI platform for assessing and triaging skin lesions on urgent suspected skin cancer pathways, deployed with health-system partners and supported by Class III CE certification for autonomous clinical decisions.
Extracted from the linked company product description already verified on Brel. No capabilities were invented.